Assignee
MILLENDO THERAPEUTICS INC
US·2 granted patents·3 pending applications·5 citations·filing 2016–2019
Top patents by PatentIndex Score
5 records- 0181US9877937B2Compounds and methods for treating aberrant adrenocortical cell disordersMILLENDO THERAPEUTICS INC·Filed 2016·Granted Jan 30, 2018·5 cites·1 claims
- 0266US2020255372A1Solid drug form of n-(2,6-bis(1-methylethyl)phenyl)-n'-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea hydrochloride and compositions, methods and kits related theretoMILLENDO THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0354US10059660B2Solid drug form of N-(2,6-bis(1-methylethyl)phenyl)-N′-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea hydrochloride and compositions, methods and kits related theretoMILLENDO THERAPEUTICS INC·Filed 2016·Granted Aug 28, 2018·0 cites·6 claims
- 0445US2018200209A1Enhanced bioavailability of n-(2,6-bis(1-methylethyl)phenyl)-n'-((1-(4-(dimethylamino)-phenyl)cyclopentyl)methyl)urea hydrochlorideMILLENDO THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 0529US2016287565A1Combination therapy for treating disorders associated with excess cortisol productionMILLENDO THERAPEUTICS INC·Filed 2016·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →